“An Amazing Transformation!” The Lived Experiences of Elexacaftor/Tezacaftor/Ivacaftor in Adults with Cystic Fibrosis
Participants consistently described their experiences with ETI in positive terms. The results of this study confirm that ETI is in fact perceived to be a "miracle drug" and has had a transformative effect on the everyday lives of adults with CF through improved HRQoL and overall wellbeing, which led to positive views regarding their future with CF and ongoing medical care.
Authors
- Sona Vekaria
- Kylie Hill (ORCID: https://orcid.org/0000-0002-6082-6352)
- Naomi Chapman (ORCID: https://orcid.org/0000-0001-7270-7804)
- Daniel F. Gucciardi (ORCID: https://orcid.org/0000-0001-5448-3990)
- Vinícius Cavalheri (ORCID: https://orcid.org/0000-0001-8620-7499)
- Siobhain Mulrennan (ORCID: https://orcid.org/0000-0001-7480-4835)
Institutions
- The University of Western Australia (AU)
- Curtin University (AU)
- Government of Western Australia Department of Health (AU)
- Sir Charles Gairdner Hospital (AU)
- North Metropolitan Health Service (AU)
- Institute for Respiratory Health (AU)
Publication Details
- Journal
- Respiration
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1159/000549098
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cystic Fibrosis in Australia
- Australian Cystic Fibrosis Research Trust
- Curtin University of Technology